Review



rabbit polyclonal anti pdia3 primary antibody  (Proteintech)


Bioz Verified Symbol Proteintech is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 98

    Structured Review

    Proteintech rabbit polyclonal anti pdia3 primary antibody
    <t>PDIA3</t> expression is up-regulated in OSCC tissues. (A and B) The mRNA expression of PDIA3 in the normal and OSCC tissues in the OSCC dataset from TCGA. (A) Compare all tumor and normal tissues. (B) Only compare paired tumors and normal tissues. (C) The protein expression of PDIA3 by IHC was retrieved from the HPA database. (D) The immunofluorescent staining of PDIA3 in human OSCC tissues and non-tumorous tissues. Left, representative images; right, quantification of the intensity of the PDIA3 staining. Bar = 20 μm. (E) The IHC staining of PDIA3 in human OSCC tissues and normal tissues. Left, representative IHC images. Upper: bar = 200 μm; lower: bar = 50 μm. Right, quantification of the intensity of the PDIA3 staining. (F) PDIA3 mRNA expression in normal tissues and tumors at different T stages. (G) PDIA3 level in normal tissues and OSCC tumors at different N stages. ***, P < 0.001. A P < 0.05 is significantly different.
    Rabbit Polyclonal Anti Pdia3 Primary Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 98/100, based on 8823 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+polyclonal+anti+pdia3+primary+antibody/Goat+anti-rabbit+IgG+(H%2BL)%2C+HRP+conjugate/pmc10782160-93-7-13
    Average 98 stars, based on 8823 article reviews
    rabbit polyclonal anti pdia3 primary antibody - by Bioz Stars, 2026-09
    98/100 stars

    Images

    1) Product Images from "The role of PDIA3 in oral squamous cell carcinoma and its value as A diagnostic and prognostic biomarker"

    Article Title: The role of PDIA3 in oral squamous cell carcinoma and its value as A diagnostic and prognostic biomarker

    Journal: Heliyon

    doi: 10.1016/j.heliyon.2023.e22596

    PDIA3 expression is up-regulated in OSCC tissues. (A and B) The mRNA expression of PDIA3 in the normal and OSCC tissues in the OSCC dataset from TCGA. (A) Compare all tumor and normal tissues. (B) Only compare paired tumors and normal tissues. (C) The protein expression of PDIA3 by IHC was retrieved from the HPA database. (D) The immunofluorescent staining of PDIA3 in human OSCC tissues and non-tumorous tissues. Left, representative images; right, quantification of the intensity of the PDIA3 staining. Bar = 20 μm. (E) The IHC staining of PDIA3 in human OSCC tissues and normal tissues. Left, representative IHC images. Upper: bar = 200 μm; lower: bar = 50 μm. Right, quantification of the intensity of the PDIA3 staining. (F) PDIA3 mRNA expression in normal tissues and tumors at different T stages. (G) PDIA3 level in normal tissues and OSCC tumors at different N stages. ***, P < 0.001. A P < 0.05 is significantly different.
    Figure Legend Snippet: PDIA3 expression is up-regulated in OSCC tissues. (A and B) The mRNA expression of PDIA3 in the normal and OSCC tissues in the OSCC dataset from TCGA. (A) Compare all tumor and normal tissues. (B) Only compare paired tumors and normal tissues. (C) The protein expression of PDIA3 by IHC was retrieved from the HPA database. (D) The immunofluorescent staining of PDIA3 in human OSCC tissues and non-tumorous tissues. Left, representative images; right, quantification of the intensity of the PDIA3 staining. Bar = 20 μm. (E) The IHC staining of PDIA3 in human OSCC tissues and normal tissues. Left, representative IHC images. Upper: bar = 200 μm; lower: bar = 50 μm. Right, quantification of the intensity of the PDIA3 staining. (F) PDIA3 mRNA expression in normal tissues and tumors at different T stages. (G) PDIA3 level in normal tissues and OSCC tumors at different N stages. ***, P < 0.001. A P < 0.05 is significantly different.

    Techniques Used: Expressing, Staining, Immunohistochemistry

    The diagnostic and prognostic value of PDIA3 in OSCC. The PDIA3 expression and clinical data were retrieved from the OSCC dataset in TCGA. (A) The ROC curve for analyzing the value of PDIA3 in the diagnosis of OSCC. (B–D) The Kaplan-Meier method was used to analyze the value of PDIA3 in predicting the prognosis of OSCC patients. The Kaplan-Meier curves for (B) OS, (C) DSS and (D) PFI are shown here. The Logrank test was used to compare the curves. A P < 0.05 is significantly different.
    Figure Legend Snippet: The diagnostic and prognostic value of PDIA3 in OSCC. The PDIA3 expression and clinical data were retrieved from the OSCC dataset in TCGA. (A) The ROC curve for analyzing the value of PDIA3 in the diagnosis of OSCC. (B–D) The Kaplan-Meier method was used to analyze the value of PDIA3 in predicting the prognosis of OSCC patients. The Kaplan-Meier curves for (B) OS, (C) DSS and (D) PFI are shown here. The Logrank test was used to compare the curves. A P < 0.05 is significantly different.

    Techniques Used: Diagnostic Assay, Expressing, Biomarker Discovery

    Univariate and multivariate Cox regression analysis of  PDIA3  in OSCC.
    Figure Legend Snippet: Univariate and multivariate Cox regression analysis of PDIA3 in OSCC.

    Techniques Used:

    Down-regulation of PDIA3 inhibits the cancerous phenotypes of OSCC cells. The CAL27 and SCC25 cells were transfected with siRNA oligos targeting PDIA3 (designated as siPDIA3). Cells transfected with non-targeting oligos were used as controls (siNC). The untreated cells were also used and designated as ctrl. (A and B) Immunoblotting was performed to measure the protein level of PDIA3 in (A) CAL27 and (B) SCC25 cells. (C and D) The cell viability was measured by CCK8 assay on 24, 48, 72, and 96 h in (C) CAL27 and (D) SCC25 cells transfected with siPDIA3 or non-targeting siRNA. (E and F) The apoptosis of (E) CAL27 and (F) SCC25 cells was measured using an ELISA assay detecting the level of cytosolic nucleosomes. (G and H) The migratory ability of siRNA-transfected (G) CAL27 and (H) SCC25 cells was evaluated using a wound healing assay. Left: representative images; right: quantification of the wound healing rates. Scale bar = 100 μm *, P < 0.05, **, P < 0.01, ***, P < 0.001. A P < 0.05 is significantly different.
    Figure Legend Snippet: Down-regulation of PDIA3 inhibits the cancerous phenotypes of OSCC cells. The CAL27 and SCC25 cells were transfected with siRNA oligos targeting PDIA3 (designated as siPDIA3). Cells transfected with non-targeting oligos were used as controls (siNC). The untreated cells were also used and designated as ctrl. (A and B) Immunoblotting was performed to measure the protein level of PDIA3 in (A) CAL27 and (B) SCC25 cells. (C and D) The cell viability was measured by CCK8 assay on 24, 48, 72, and 96 h in (C) CAL27 and (D) SCC25 cells transfected with siPDIA3 or non-targeting siRNA. (E and F) The apoptosis of (E) CAL27 and (F) SCC25 cells was measured using an ELISA assay detecting the level of cytosolic nucleosomes. (G and H) The migratory ability of siRNA-transfected (G) CAL27 and (H) SCC25 cells was evaluated using a wound healing assay. Left: representative images; right: quantification of the wound healing rates. Scale bar = 100 μm *, P < 0.05, **, P < 0.01, ***, P < 0.001. A P < 0.05 is significantly different.

    Techniques Used: Transfection, Western Blot, CCK-8 Assay, Enzyme-linked Immunosorbent Assay, Wound Healing Assay

    PDIA3 regulates the PI3K/AKT signaling pathway in OSCC. (A) The mRNA expression of PI3KCD, AKT1-3, and mTOR in OSCC and normal tissues. (B) A heatmap showing the expression levels of PI3KCD, AKT1-3, and mTOR across PDIA3 high and PDIA3 low OSCC tissues. Red: high expression level; blue: low expression level. (C) The correlation between PDIA3 and PI3KCD, AKT1-3, or mTOR was analyzed by Spearman's correlation analysis. (D and E) PDIA3 was silenced by siRNA transfection (siPDIA3). Cells transfected with non-targeting siRNA (siNC) and untreated cells (ctrl) were used as controls. The levels of phosphor-AKT and total AKT were measured by immunoblotting in (D) CAL27 and (E) SCC25 cells. *, P < 0.05, **, P < 0.01, ***, P < 0.001. A P < 0.05 is significantly different.
    Figure Legend Snippet: PDIA3 regulates the PI3K/AKT signaling pathway in OSCC. (A) The mRNA expression of PI3KCD, AKT1-3, and mTOR in OSCC and normal tissues. (B) A heatmap showing the expression levels of PI3KCD, AKT1-3, and mTOR across PDIA3 high and PDIA3 low OSCC tissues. Red: high expression level; blue: low expression level. (C) The correlation between PDIA3 and PI3KCD, AKT1-3, or mTOR was analyzed by Spearman's correlation analysis. (D and E) PDIA3 was silenced by siRNA transfection (siPDIA3). Cells transfected with non-targeting siRNA (siNC) and untreated cells (ctrl) were used as controls. The levels of phosphor-AKT and total AKT were measured by immunoblotting in (D) CAL27 and (E) SCC25 cells. *, P < 0.05, **, P < 0.01, ***, P < 0.001. A P < 0.05 is significantly different.

    Techniques Used: Expressing, Transfection, Western Blot

    PDIA3 single-gene GSEA functional enrichment analysis. The GSEA for the differential genes related to PDIA3. (A) Enriched functions of the down-regulated genes. (B) Enriched functions of the up-regulated genes. (C) A lollipop plot showing the correlation between PDIA3 expression and immune cell infiltration in OSCC tissues by Spearman analysis. *, P < 0.05, **, P < 0.01, ***, P < 0.001, n.s, not significant. A P < 0.05 is significantly different.
    Figure Legend Snippet: PDIA3 single-gene GSEA functional enrichment analysis. The GSEA for the differential genes related to PDIA3. (A) Enriched functions of the down-regulated genes. (B) Enriched functions of the up-regulated genes. (C) A lollipop plot showing the correlation between PDIA3 expression and immune cell infiltration in OSCC tissues by Spearman analysis. *, P < 0.05, **, P < 0.01, ***, P < 0.001, n.s, not significant. A P < 0.05 is significantly different.

    Techniques Used: Functional Assay, Expressing

    Related Articles

    Incubation:

    Article Title: The role of PDIA3 in oral squamous cell carcinoma and its value as A diagnostic and prognostic biomarker
    Article Snippet: .. After overnight incubation at 4 °C with rabbit polyclonal anti-PDIA3 primary antibody (1:300, Proteintech, USA), the slides were incubated with HRP-goat anti-rabbit IgG secondary antibody (Boster Biological Technology Co. Ltd, China) at 37 °C for 30 min and washed with PBS three times. .. The slides were incubated with DAB (Boster Biological Technology Co. Ltd, China), re-stained with hematoxylin, and differentiated with 0.1 % HCl alcohol for 1 s. Finally, the slides were dried by gradient alcohol dehydration, made transparent with xylene, and sealed with neutral gum.



    Similar Products

    98
    Proteintech rabbit polyclonal anti pdia3 primary antibody
    <t>PDIA3</t> expression is up-regulated in OSCC tissues. (A and B) The mRNA expression of PDIA3 in the normal and OSCC tissues in the OSCC dataset from TCGA. (A) Compare all tumor and normal tissues. (B) Only compare paired tumors and normal tissues. (C) The protein expression of PDIA3 by IHC was retrieved from the HPA database. (D) The immunofluorescent staining of PDIA3 in human OSCC tissues and non-tumorous tissues. Left, representative images; right, quantification of the intensity of the PDIA3 staining. Bar = 20 μm. (E) The IHC staining of PDIA3 in human OSCC tissues and normal tissues. Left, representative IHC images. Upper: bar = 200 μm; lower: bar = 50 μm. Right, quantification of the intensity of the PDIA3 staining. (F) PDIA3 mRNA expression in normal tissues and tumors at different T stages. (G) PDIA3 level in normal tissues and OSCC tumors at different N stages. ***, P < 0.001. A P < 0.05 is significantly different.
    Rabbit Polyclonal Anti Pdia3 Primary Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+polyclonal+anti+pdia3+primary+antibody/Goat+anti-rabbit+IgG+(H%2BL)%2C+HRP+conjugate/pmc10782160-93-7-13
    Average 98 stars, based on 1 article reviews
    rabbit polyclonal anti pdia3 primary antibody - by Bioz Stars, 2026-09
    98/100 stars
      Buy from Supplier

    90
    Millipore anti-pdia3 rabbit polyclonal primary antibody
    <t>PDIA3</t> expression is up-regulated in OSCC tissues. (A and B) The mRNA expression of PDIA3 in the normal and OSCC tissues in the OSCC dataset from TCGA. (A) Compare all tumor and normal tissues. (B) Only compare paired tumors and normal tissues. (C) The protein expression of PDIA3 by IHC was retrieved from the HPA database. (D) The immunofluorescent staining of PDIA3 in human OSCC tissues and non-tumorous tissues. Left, representative images; right, quantification of the intensity of the PDIA3 staining. Bar = 20 μm. (E) The IHC staining of PDIA3 in human OSCC tissues and normal tissues. Left, representative IHC images. Upper: bar = 200 μm; lower: bar = 50 μm. Right, quantification of the intensity of the PDIA3 staining. (F) PDIA3 mRNA expression in normal tissues and tumors at different T stages. (G) PDIA3 level in normal tissues and OSCC tumors at different N stages. ***, P < 0.001. A P < 0.05 is significantly different.
    Anti Pdia3 Rabbit Polyclonal Primary Antibody, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+polyclonal+anti+pdia3+primary+antibody/anti+pdia3+rabbit+polyclonal+primary+antibody/pm36769334-329-40-46
    Average 90 stars, based on 1 article reviews
    anti-pdia3 rabbit polyclonal primary antibody - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Merck KGaA anti-pdia3 rabbit polyclonal primary antibody abe1032
    <t>PDIA3</t> expression is up-regulated in OSCC tissues. (A and B) The mRNA expression of PDIA3 in the normal and OSCC tissues in the OSCC dataset from TCGA. (A) Compare all tumor and normal tissues. (B) Only compare paired tumors and normal tissues. (C) The protein expression of PDIA3 by IHC was retrieved from the HPA database. (D) The immunofluorescent staining of PDIA3 in human OSCC tissues and non-tumorous tissues. Left, representative images; right, quantification of the intensity of the PDIA3 staining. Bar = 20 μm. (E) The IHC staining of PDIA3 in human OSCC tissues and normal tissues. Left, representative IHC images. Upper: bar = 200 μm; lower: bar = 50 μm. Right, quantification of the intensity of the PDIA3 staining. (F) PDIA3 mRNA expression in normal tissues and tumors at different T stages. (G) PDIA3 level in normal tissues and OSCC tumors at different N stages. ***, P < 0.001. A P < 0.05 is significantly different.
    Anti Pdia3 Rabbit Polyclonal Primary Antibody Abe1032, supplied by Merck KGaA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+polyclonal+anti+pdia3+primary+antibody/anti+pdia3+rabbit+polyclonal+primary+antibody+abe1032/pm36769334-322-1-11
    Average 90 stars, based on 1 article reviews
    anti-pdia3 rabbit polyclonal primary antibody abe1032 - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    Image Search Results


    PDIA3 expression is up-regulated in OSCC tissues. (A and B) The mRNA expression of PDIA3 in the normal and OSCC tissues in the OSCC dataset from TCGA. (A) Compare all tumor and normal tissues. (B) Only compare paired tumors and normal tissues. (C) The protein expression of PDIA3 by IHC was retrieved from the HPA database. (D) The immunofluorescent staining of PDIA3 in human OSCC tissues and non-tumorous tissues. Left, representative images; right, quantification of the intensity of the PDIA3 staining. Bar = 20 μm. (E) The IHC staining of PDIA3 in human OSCC tissues and normal tissues. Left, representative IHC images. Upper: bar = 200 μm; lower: bar = 50 μm. Right, quantification of the intensity of the PDIA3 staining. (F) PDIA3 mRNA expression in normal tissues and tumors at different T stages. (G) PDIA3 level in normal tissues and OSCC tumors at different N stages. ***, P < 0.001. A P < 0.05 is significantly different.

    Journal: Heliyon

    Article Title: The role of PDIA3 in oral squamous cell carcinoma and its value as A diagnostic and prognostic biomarker

    doi: 10.1016/j.heliyon.2023.e22596

    Figure Lengend Snippet: PDIA3 expression is up-regulated in OSCC tissues. (A and B) The mRNA expression of PDIA3 in the normal and OSCC tissues in the OSCC dataset from TCGA. (A) Compare all tumor and normal tissues. (B) Only compare paired tumors and normal tissues. (C) The protein expression of PDIA3 by IHC was retrieved from the HPA database. (D) The immunofluorescent staining of PDIA3 in human OSCC tissues and non-tumorous tissues. Left, representative images; right, quantification of the intensity of the PDIA3 staining. Bar = 20 μm. (E) The IHC staining of PDIA3 in human OSCC tissues and normal tissues. Left, representative IHC images. Upper: bar = 200 μm; lower: bar = 50 μm. Right, quantification of the intensity of the PDIA3 staining. (F) PDIA3 mRNA expression in normal tissues and tumors at different T stages. (G) PDIA3 level in normal tissues and OSCC tumors at different N stages. ***, P < 0.001. A P < 0.05 is significantly different.

    Article Snippet: After overnight incubation at 4 °C with rabbit polyclonal anti-PDIA3 primary antibody (1:300, Proteintech, USA), the slides were incubated with HRP-goat anti-rabbit IgG secondary antibody (Boster Biological Technology Co. Ltd, China) at 37 °C for 30 min and washed with PBS three times.

    Techniques: Expressing, Staining, Immunohistochemistry

    The diagnostic and prognostic value of PDIA3 in OSCC. The PDIA3 expression and clinical data were retrieved from the OSCC dataset in TCGA. (A) The ROC curve for analyzing the value of PDIA3 in the diagnosis of OSCC. (B–D) The Kaplan-Meier method was used to analyze the value of PDIA3 in predicting the prognosis of OSCC patients. The Kaplan-Meier curves for (B) OS, (C) DSS and (D) PFI are shown here. The Logrank test was used to compare the curves. A P < 0.05 is significantly different.

    Journal: Heliyon

    Article Title: The role of PDIA3 in oral squamous cell carcinoma and its value as A diagnostic and prognostic biomarker

    doi: 10.1016/j.heliyon.2023.e22596

    Figure Lengend Snippet: The diagnostic and prognostic value of PDIA3 in OSCC. The PDIA3 expression and clinical data were retrieved from the OSCC dataset in TCGA. (A) The ROC curve for analyzing the value of PDIA3 in the diagnosis of OSCC. (B–D) The Kaplan-Meier method was used to analyze the value of PDIA3 in predicting the prognosis of OSCC patients. The Kaplan-Meier curves for (B) OS, (C) DSS and (D) PFI are shown here. The Logrank test was used to compare the curves. A P < 0.05 is significantly different.

    Article Snippet: After overnight incubation at 4 °C with rabbit polyclonal anti-PDIA3 primary antibody (1:300, Proteintech, USA), the slides were incubated with HRP-goat anti-rabbit IgG secondary antibody (Boster Biological Technology Co. Ltd, China) at 37 °C for 30 min and washed with PBS three times.

    Techniques: Diagnostic Assay, Expressing, Biomarker Discovery

    Univariate and multivariate Cox regression analysis of  PDIA3  in OSCC.

    Journal: Heliyon

    Article Title: The role of PDIA3 in oral squamous cell carcinoma and its value as A diagnostic and prognostic biomarker

    doi: 10.1016/j.heliyon.2023.e22596

    Figure Lengend Snippet: Univariate and multivariate Cox regression analysis of PDIA3 in OSCC.

    Article Snippet: After overnight incubation at 4 °C with rabbit polyclonal anti-PDIA3 primary antibody (1:300, Proteintech, USA), the slides were incubated with HRP-goat anti-rabbit IgG secondary antibody (Boster Biological Technology Co. Ltd, China) at 37 °C for 30 min and washed with PBS three times.

    Techniques:

    Down-regulation of PDIA3 inhibits the cancerous phenotypes of OSCC cells. The CAL27 and SCC25 cells were transfected with siRNA oligos targeting PDIA3 (designated as siPDIA3). Cells transfected with non-targeting oligos were used as controls (siNC). The untreated cells were also used and designated as ctrl. (A and B) Immunoblotting was performed to measure the protein level of PDIA3 in (A) CAL27 and (B) SCC25 cells. (C and D) The cell viability was measured by CCK8 assay on 24, 48, 72, and 96 h in (C) CAL27 and (D) SCC25 cells transfected with siPDIA3 or non-targeting siRNA. (E and F) The apoptosis of (E) CAL27 and (F) SCC25 cells was measured using an ELISA assay detecting the level of cytosolic nucleosomes. (G and H) The migratory ability of siRNA-transfected (G) CAL27 and (H) SCC25 cells was evaluated using a wound healing assay. Left: representative images; right: quantification of the wound healing rates. Scale bar = 100 μm *, P < 0.05, **, P < 0.01, ***, P < 0.001. A P < 0.05 is significantly different.

    Journal: Heliyon

    Article Title: The role of PDIA3 in oral squamous cell carcinoma and its value as A diagnostic and prognostic biomarker

    doi: 10.1016/j.heliyon.2023.e22596

    Figure Lengend Snippet: Down-regulation of PDIA3 inhibits the cancerous phenotypes of OSCC cells. The CAL27 and SCC25 cells were transfected with siRNA oligos targeting PDIA3 (designated as siPDIA3). Cells transfected with non-targeting oligos were used as controls (siNC). The untreated cells were also used and designated as ctrl. (A and B) Immunoblotting was performed to measure the protein level of PDIA3 in (A) CAL27 and (B) SCC25 cells. (C and D) The cell viability was measured by CCK8 assay on 24, 48, 72, and 96 h in (C) CAL27 and (D) SCC25 cells transfected with siPDIA3 or non-targeting siRNA. (E and F) The apoptosis of (E) CAL27 and (F) SCC25 cells was measured using an ELISA assay detecting the level of cytosolic nucleosomes. (G and H) The migratory ability of siRNA-transfected (G) CAL27 and (H) SCC25 cells was evaluated using a wound healing assay. Left: representative images; right: quantification of the wound healing rates. Scale bar = 100 μm *, P < 0.05, **, P < 0.01, ***, P < 0.001. A P < 0.05 is significantly different.

    Article Snippet: After overnight incubation at 4 °C with rabbit polyclonal anti-PDIA3 primary antibody (1:300, Proteintech, USA), the slides were incubated with HRP-goat anti-rabbit IgG secondary antibody (Boster Biological Technology Co. Ltd, China) at 37 °C for 30 min and washed with PBS three times.

    Techniques: Transfection, Western Blot, CCK-8 Assay, Enzyme-linked Immunosorbent Assay, Wound Healing Assay

    PDIA3 regulates the PI3K/AKT signaling pathway in OSCC. (A) The mRNA expression of PI3KCD, AKT1-3, and mTOR in OSCC and normal tissues. (B) A heatmap showing the expression levels of PI3KCD, AKT1-3, and mTOR across PDIA3 high and PDIA3 low OSCC tissues. Red: high expression level; blue: low expression level. (C) The correlation between PDIA3 and PI3KCD, AKT1-3, or mTOR was analyzed by Spearman's correlation analysis. (D and E) PDIA3 was silenced by siRNA transfection (siPDIA3). Cells transfected with non-targeting siRNA (siNC) and untreated cells (ctrl) were used as controls. The levels of phosphor-AKT and total AKT were measured by immunoblotting in (D) CAL27 and (E) SCC25 cells. *, P < 0.05, **, P < 0.01, ***, P < 0.001. A P < 0.05 is significantly different.

    Journal: Heliyon

    Article Title: The role of PDIA3 in oral squamous cell carcinoma and its value as A diagnostic and prognostic biomarker

    doi: 10.1016/j.heliyon.2023.e22596

    Figure Lengend Snippet: PDIA3 regulates the PI3K/AKT signaling pathway in OSCC. (A) The mRNA expression of PI3KCD, AKT1-3, and mTOR in OSCC and normal tissues. (B) A heatmap showing the expression levels of PI3KCD, AKT1-3, and mTOR across PDIA3 high and PDIA3 low OSCC tissues. Red: high expression level; blue: low expression level. (C) The correlation between PDIA3 and PI3KCD, AKT1-3, or mTOR was analyzed by Spearman's correlation analysis. (D and E) PDIA3 was silenced by siRNA transfection (siPDIA3). Cells transfected with non-targeting siRNA (siNC) and untreated cells (ctrl) were used as controls. The levels of phosphor-AKT and total AKT were measured by immunoblotting in (D) CAL27 and (E) SCC25 cells. *, P < 0.05, **, P < 0.01, ***, P < 0.001. A P < 0.05 is significantly different.

    Article Snippet: After overnight incubation at 4 °C with rabbit polyclonal anti-PDIA3 primary antibody (1:300, Proteintech, USA), the slides were incubated with HRP-goat anti-rabbit IgG secondary antibody (Boster Biological Technology Co. Ltd, China) at 37 °C for 30 min and washed with PBS three times.

    Techniques: Expressing, Transfection, Western Blot

    PDIA3 single-gene GSEA functional enrichment analysis. The GSEA for the differential genes related to PDIA3. (A) Enriched functions of the down-regulated genes. (B) Enriched functions of the up-regulated genes. (C) A lollipop plot showing the correlation between PDIA3 expression and immune cell infiltration in OSCC tissues by Spearman analysis. *, P < 0.05, **, P < 0.01, ***, P < 0.001, n.s, not significant. A P < 0.05 is significantly different.

    Journal: Heliyon

    Article Title: The role of PDIA3 in oral squamous cell carcinoma and its value as A diagnostic and prognostic biomarker

    doi: 10.1016/j.heliyon.2023.e22596

    Figure Lengend Snippet: PDIA3 single-gene GSEA functional enrichment analysis. The GSEA for the differential genes related to PDIA3. (A) Enriched functions of the down-regulated genes. (B) Enriched functions of the up-regulated genes. (C) A lollipop plot showing the correlation between PDIA3 expression and immune cell infiltration in OSCC tissues by Spearman analysis. *, P < 0.05, **, P < 0.01, ***, P < 0.001, n.s, not significant. A P < 0.05 is significantly different.

    Article Snippet: After overnight incubation at 4 °C with rabbit polyclonal anti-PDIA3 primary antibody (1:300, Proteintech, USA), the slides were incubated with HRP-goat anti-rabbit IgG secondary antibody (Boster Biological Technology Co. Ltd, China) at 37 °C for 30 min and washed with PBS three times.

    Techniques: Functional Assay, Expressing